Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.

Journal of gastrointestinal and liver diseases : JGLD

Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T

2008 J Gastrointestin Liver Dis Volume 17 Issue 2

PubMed 18568141 DOI None

Review FibroTest ActiTest SteatoTest NashTest AshTest HCV HBV HIV co-infected Metabolic Diseases Alcohol Fibrosis Steatosis Activity/Inflammation Diabetes Hypertension OverWeight HyperLipidemia

Citation Reference: